{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:10:07Z","timestamp":1782958207765,"version":"3.54.5"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T00:00:00Z","timestamp":1262822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12035-009-8092-x","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T00:30:52Z","timestamp":1262737852000},"page":"97-106","source":"Crossref","is-referenced-by-count":42,"title":["The Pathogenic Implication of Abnormal Interaction Between Apolipoprotein E Isoforms, Amyloid-beta Peptides, and Sulfatides in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Xianlin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,7]]},"reference":[{"key":"8092_CR1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm0896-850","volume":"2","author":"BA Yankner","year":"1996","unstructured":"Yankner BA (1996) New clues to Alzheimer's disease: unraveling the roles of amyloid and tau. Nat Med 2:850\u2013852","journal-title":"Nat Med"},{"key":"8092_CR2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.275.5300.630","volume":"275","author":"DJ Selkoe","year":"1997","unstructured":"Selkoe DJ (1997) Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275:630\u2013631","journal-title":"Science"},{"key":"8092_CR3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0197-4580(02)00040-4","volume":"23","author":"DM Holtzman","year":"2002","unstructured":"Holtzman DM (2002) Abeta conformational change is central to Alzheimer's disease. Neurobiol Aging 23:1085\u20131088","journal-title":"Neurobiol Aging"},{"key":"8092_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jnr.10355","volume":"70","author":"M Morishima-Kawashima","year":"2002","unstructured":"Morishima-Kawashima M, Ihara Y (2002) Alzheimer's disease: beta-amyloid protein and tau. J Neurosci Res 70:392\u2013401","journal-title":"J Neurosci Res"},{"key":"8092_CR5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(03)00124-6","volume":"27","author":"EG McGeer","year":"2003","unstructured":"McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27:741\u2013749","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8092_CR6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nm0706-758","volume":"12","author":"DJ Selkoe","year":"2006","unstructured":"Selkoe DJ (2006) The ups and downs of Abeta. Nat Med 12:758\u2013759, discussion 759","journal-title":"Nat Med"},{"key":"8092_CR7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.410170310","volume":"17","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17:278\u2013282","journal-title":"Ann Neurol"},{"key":"8092_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/biof.37","volume":"35","author":"J Fan","year":"2009","unstructured":"Fan J, Donkin J, Wellington C (2009) Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Biofactors 35:239\u2013248","journal-title":"Biofactors"},{"key":"8092_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","volume":"65","author":"AM Fagan","year":"2009","unstructured":"Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, Holtzman DM (2009) Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol 65:176\u2013183","journal-title":"Ann Neurol"},{"key":"8092_CR10","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","volume":"29","author":"S Mandrekar","year":"2009","unstructured":"Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29:4252\u20134262","journal-title":"J Neurosci"},{"key":"8092_CR11","doi-asserted-by":"crossref","first-page":"36180","DOI":"10.1074\/jbc.M604436200","volume":"281","author":"CV Zerbinatti","year":"2006","unstructured":"Zerbinatti CV, Wahrle SE, Kim H, Cam JA, Bales K, Paul SM, Holtzman DM, Bu G (2006) Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice. J Biol Chem 281:36180\u201336186","journal-title":"J Biol Chem"},{"key":"8092_CR12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neurobiolaging.2004.09.018","volume":"26","author":"RA Nixon","year":"2005","unstructured":"Nixon RA (2005) Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol Aging 26:373\u2013382","journal-title":"Neurobiol Aging"},{"key":"8092_CR13","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1073\/pnas.89.16.7437","volume":"89","author":"MF Knauer","year":"1992","unstructured":"Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG (1992) Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4\/beta protein. Proc Natl Acad Sci U S A 89:7437\u20137441","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8092_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-8993(96)01262-0","volume":"746","author":"D Burdick","year":"1997","unstructured":"Burdick D, Kosmoski J, Knauer MF, Glabe CG (1997) Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Res 746:275\u2013284","journal-title":"Brain Res"},{"key":"8092_CR15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622\u2013630","journal-title":"Science"},{"key":"8092_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-0186(01)00049-3","volume":"39","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer J, Sullivan PM, Fagan AM, Han X, Holtzman DM (2001) Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem Int 39:415\u2013425","journal-title":"Neurochem Int"},{"key":"8092_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.nu.15.070195.002431","volume":"15","author":"AS Plump","year":"1995","unstructured":"Plump AS, Breslow JL (1995) Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr 15:495\u2013518","journal-title":"Annu Rev Nutr"},{"key":"8092_CR18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","volume":"4","author":"LA Shobab","year":"2005","unstructured":"Shobab LA, Hsiung G-YR, Feldman HH (2005) Cholesterol in Alzheimer's disease. Lancet Neurology 4:841\u2013852","journal-title":"Lancet Neurology"},{"key":"8092_CR19","doi-asserted-by":"crossref","first-page":"11302","DOI":"10.1074\/jbc.M801520200","volume":"283","author":"MO Grimm","year":"2008","unstructured":"Grimm MO, Grimm HS, Tomic I, Beyreuther K, Hartmann T, Bergmann C (2008) Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J Biol Chem 283:11302\u201311311","journal-title":"J Biol Chem"},{"key":"8092_CR20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI109047","volume":"61","author":"LK Curtiss","year":"1978","unstructured":"Curtiss LK, Edgington TS (1978) Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. J Clin Invest 61:1298\u20131308","journal-title":"J Clin Invest"},{"key":"8092_CR21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","volume":"135","author":"T Wisniewski","year":"1992","unstructured":"Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135:235\u2013238","journal-title":"Neurosci Lett"},{"key":"8092_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1073\/pnas.82.1.203","volume":"82","author":"NA Elshourbagy","year":"1985","unstructured":"Elshourbagy NA, Liao WS, Mahley RW, Taylor JM (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A 82:203\u2013207","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8092_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","volume":"917","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917:148\u2013161","journal-title":"Biochim Biophys Acta"},{"key":"8092_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","volume":"19","author":"WJ Strittmatter","year":"1996","unstructured":"Strittmatter WJ, Roses AD (1996) Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 19:53\u201377","journal-title":"Annu Rev Neurosci"},{"key":"8092_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2760(94)90262-3","volume":"1211","author":"JP Vos","year":"1994","unstructured":"Vos JP, Lopes-Cardozo M, Gadella BM (1994) Metabolic and functional aspects of sulfogalactolipids. Biochim Biophys Acta 1211:125\u2013149","journal-title":"Biochim Biophys Acta"},{"key":"8092_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0163-7827(97)00011-8","volume":"36","author":"I Ishizuka","year":"1997","unstructured":"Ishizuka I (1997) Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 36:245\u2013319","journal-title":"Prog Lipid Res"},{"key":"8092_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0076-6879(00)11105-X","volume":"311","author":"T Ikami","year":"2000","unstructured":"Ikami T, Ishida H, Kiso M (2000) Synthesis and biological activity of glycolipids, with a focus on gangliosides and sulfatide analogs. Methods Enzymol 311:547\u2013568","journal-title":"Methods Enzymol"},{"key":"8092_CR28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0304-4165(02)00410-5","volume":"1573","author":"J Marcus","year":"2002","unstructured":"Marcus J, Popko B (2002) Galactolipids are molecular determinants of myelin development and axo-glial organization. Biochim Biophys Acta 1573:406\u2013413","journal-title":"Biochim Biophys Acta"},{"key":"8092_CR29","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1523\/JNEUROSCI.2329-07.2007","volume":"27","author":"M Eckhardt","year":"2007","unstructured":"Eckhardt M, Hedayati KK, Pitsch J, Lullmann-Rauch R, Beck H, Fewou SN, Gieselmann V (2007) Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy. J Neurosci 27:9009\u20139021","journal-title":"J Neurosci"},{"key":"8092_CR30","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/j.1742-4658.2006.05195.x","volume":"273","author":"G Isaac","year":"2006","unstructured":"Isaac G, Pernber Z, Gieselmann V, Hansson E, Bergquist J, Mansson JE (2006) Sulfatide with short fatty acid dominates in astrocytes and neurons. Febs J 273:1782\u20131790","journal-title":"Febs J"},{"key":"8092_CR31","first-page":"3695","volume-title":"The metabolic and molecular bases of inherited diseases","author":"K Figura von","year":"2001","unstructured":"von Figura K, Gieselmann V, Jaeken J (2001) Metachromatic leukodystrophy: lysosomal disorders. In: Sachdev HS, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited diseases. McGraw-Hill, New York, pp 3695\u20133724"},{"key":"8092_CR32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/B:NEUR.0000046572.53905.2c","volume":"33","author":"M Molander-Melin","year":"2004","unstructured":"Molander-Melin M, Pernber Z, Franken S, Gieselmann V, Mansson JE, Fredman P (2004) Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice. J Neurocytol 33:417\u2013427","journal-title":"J Neurocytol"},{"key":"8092_CR33","doi-asserted-by":"crossref","first-page":"13280","DOI":"10.1073\/pnas.93.23.13280","volume":"93","author":"A Bosio","year":"1996","unstructured":"Bosio A, Binczek E, Stoffel W (1996) Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci U S A 93:13280\u201313285","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8092_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(00)80093-8","volume":"86","author":"T Coetzee","year":"1996","unstructured":"Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Popko B (1996) Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86:209\u2013219","journal-title":"Cell"},{"key":"8092_CR35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<613::AID-JNR6>3.0.CO;2-V","volume":"54","author":"T Coetzee","year":"1998","unstructured":"Coetzee T, Dupree JL, Popko B (1998) Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice. J Neurosci Res 54:613\u2013622","journal-title":"J Neurosci Res"},{"key":"8092_CR36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004410051051","volume":"292","author":"A Bosio","year":"1998","unstructured":"Bosio A, Bussow H, Adam J, Stoffel W (1998) Galactosphingolipids and axono-glial interaction in myelin of the central nervous system. Cell Tissue Res 292:199\u2013210","journal-title":"Cell Tissue Res"},{"key":"8092_CR37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/glia.20292","volume":"53","author":"J Marcus","year":"2006","unstructured":"Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL (2006) Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53:372\u2013381","journal-title":"Glia"},{"key":"8092_CR38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10719-007-9053-0","volume":"24","author":"R Hu","year":"2007","unstructured":"Hu R, Li G, Kamijo Y, Aoyama T, Nakajima T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A (2007) Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glycoconj J 24:565\u2013571","journal-title":"Glycoconj J"},{"key":"8092_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<43::AID-CNCR8>3.0.CO;2-I","volume":"78","author":"H Morichika","year":"1996","unstructured":"Morichika H, Hamanaka Y, Tai T, Ishizuka I (1996) Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer 78:43\u201347","journal-title":"Cancer"},{"key":"8092_CR40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1471-4159.1994.62031039.x","volume":"62","author":"L Svennerholm","year":"1994","unstructured":"Svennerholm L, Gottfries CG (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem 62:1039\u20131047","journal-title":"J Neurochem"},{"key":"8092_CR41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"X Han","year":"2002","unstructured":"Han X, Holtzman DM, McKeel DW Jr, Kelley J, Morris JC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82:809\u2013818","journal-title":"J Neurochem"},{"key":"8092_CR42","first-page":"809","volume":"49","author":"H Cheng","year":"2003","unstructured":"Cheng H, Xu J, McKeel DW Jr, Han X (2003) Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study. Cell Mol Biol 49:809\u2013818","journal-title":"Cell Mol Biol"},{"issue":"1","key":"8092_CR43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1471-4159.2007.04708.x","volume":"103","author":"X Han","year":"2007","unstructured":"Han X (2007) Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stages of Alzheimer's disease: a tale of shotgun lipidomics. J Neurochem 103(1):171\u2013179","journal-title":"J Neurochem"},{"key":"8092_CR44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0188-4409(02)00392-2","volume":"33","author":"SK Bognar","year":"2002","unstructured":"Bognar SK, Furac I, Kubat M, Cosovic C, Demarin V (2002) Croatian population data for arylsulfatase a pseudodeficiency-associated mutations in healthy subjects, and in patients with Alzheimer-type dementia and Down syndrome. Arch Med Res 33:473\u2013477","journal-title":"Arch Med Res"},{"key":"8092_CR45","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1194\/jlr.R300004-JLR200","volume":"44","author":"X Han","year":"2003","unstructured":"Han X, Gross RW (2003) Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res 44:1071\u20131079","journal-title":"J Lipid Res"},{"key":"8092_CR46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mas.20023","volume":"24","author":"X Han","year":"2005","unstructured":"Han X, Gross RW (2005) Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of the cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 24:367\u2013412","journal-title":"Mass Spectrom Rev"},{"key":"8092_CR47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/14789450.2.2.253","volume":"2","author":"X Han","year":"2005","unstructured":"Han X, Gross RW (2005) Shotgun lipidomics: multi-dimensional mass spectrometric analysis of cellular lipidomes. Expert Rev Proteomics 2:253\u2013264","journal-title":"Expert Rev Proteomics"},{"key":"8092_CR48","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.2741\/2258","volume":"12","author":"X Han","year":"2007","unstructured":"Han X (2007) Neurolipidomics: challenges and developments. Front Biosci 12:2601\u20132615","journal-title":"Front Biosci"},{"key":"8092_CR49","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1021\/ac900241u","volume":"81","author":"K Yang","year":"2009","unstructured":"Yang K, Cheng H, Gross RW, Han X (2009) Automated lipid identification and quantification by multi-dimensional mass spectrometry-based shotgun lipidomics. Anal Chem 81:4356\u20134368","journal-title":"Anal Chem"},{"key":"8092_CR50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ana.10618","volume":"54","author":"X Han","year":"2003","unstructured":"Han X, Fagan AM, Cheng H, Morris JC, Xiong C, Holtzman DM (2003) Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Ann Neurol 54:115\u2013119","journal-title":"Ann Neurol"},{"key":"8092_CR51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.10642","volume":"54","author":"MC Irizarry","year":"2003","unstructured":"Irizarry MC (2003) A turn of the sulfatide in Alzheimer's disease. Ann Neurol 54:7\u20138","journal-title":"Ann Neurol"},{"key":"8092_CR52","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1074\/jbc.M212340200","volume":"278","author":"X Han","year":"2003","unstructured":"Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM (2003) Novel role for apolipoprotein E in the central nervous system: modulation of sulfatide content. J Biol Chem 278:8043\u20138051","journal-title":"J Biol Chem"},{"key":"8092_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1471-4159.2006.04342.x","volume":"101","author":"H Cheng","year":"2007","unstructured":"Cheng H, Jiang X, Han X (2007) Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study. J Neurochem 101:57\u201376","journal-title":"J Neurochem"},{"key":"8092_CR54","author":"H Cheng","year":"2009","unstructured":"Cheng H, Zhou Y, Holtzman DM, Han X (2009) Apolipoprotein E mediates sulfatide depletion in amyloid precursor protein transgenic animal models of Alzheimer\u2019s disease. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2008.1007.1020","journal-title":"Neurobiol Aging"},{"key":"8092_CR55","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO;2-1","volume":"50","author":"E Uden Van","year":"2000","unstructured":"Van Uden E, Kang DE, Koo EH, Masliah E (2000) LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis. Microsc Res Tech 50:268\u2013272","journal-title":"Microsc Res Tech"},{"key":"8092_CR56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0169-328X(02)00203-6","volume":"104","author":"K Arelin","year":"2002","unstructured":"Arelin K, Kinoshita A, Whelan CM, Irizarry MC, Rebeck GW, Strickland DK, Hyman BT (2002) LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Brain Res Mol Brain Res 104:38\u201346","journal-title":"Brain Res Mol Brain Res"},{"key":"8092_CR57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/BJ20070976","volume":"410","author":"Y Zeng","year":"2008","unstructured":"Zeng Y, Cheng H, Jiang X, Han X (2008) Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases. Biochem J 410:81\u201392","journal-title":"Biochem J"},{"key":"8092_CR58","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977\u20131981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8092_CR59","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269:23403\u201323406","journal-title":"J Biol Chem"},{"key":"8092_CR60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM (1997) Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17:263\u2013264","journal-title":"Nat Genet"},{"key":"8092_CR61","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 97:2892\u20132897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8092_CR62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV (2004) LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43:333\u2013344","journal-title":"Neuron"},{"key":"8092_CR63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","volume":"47","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT (2000) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol 47:739\u2013747","journal-title":"Ann Neurol"},{"key":"8092_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM (2002) Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Neurobiol Dis 9:305\u2013318","journal-title":"Neurobiol Dis"},{"key":"8092_CR65","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1471-4159.1992.tb08470.x","volume":"59","author":"PE Fraser","year":"1992","unstructured":"Fraser PE, Nguyen JT, Chin DT, Kirschner DA (1992) Effects of sulfate ions on Alzheimer beta\/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem 59:1531\u20131540","journal-title":"J Neurochem"},{"key":"8092_CR66","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1471-4159.1999.721681.x","volume":"72","author":"GM Castillo","year":"1999","unstructured":"Castillo GM, Lukito W, Wight TN, Snow AD (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation. J Neurochem 72:1681\u20131687","journal-title":"J Neurochem"},{"key":"8092_CR67","first-page":"1253","volume":"137","author":"AD Snow","year":"1990","unstructured":"Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight TN (1990) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137:1253\u20131270","journal-title":"Am J Pathol"},{"key":"8092_CR68","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1750-3639.2002.tb00462.x","volume":"12","author":"J Horssen van","year":"2002","unstructured":"van Horssen J, Wilhelmus MM, Heljasvaara R, Pihlajaniemi T, Wesseling P, de Waal RM, Verbeek MM (2002) Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol 12:456\u2013462","journal-title":"Brain Pathol."},{"key":"8092_CR69","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1471-4159.2008.05481.x","volume":"106","author":"Y Zeng","year":"2008","unstructured":"Zeng Y, Han X (2008) Sulfatides facilitate apolipoprotein E-mediated amyloid-b peptide clearance through an endocytotic pathway. J Neurochem 106:1275\u20131286","journal-title":"J Neurochem"},{"key":"8092_CR70","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1096\/fj.02-1050fje","volume":"17","author":"MP Murphy","year":"2003","unstructured":"Murphy MP, Das P, Nyborg AC, Rochette MJ, Dodson MW, Loosbrock NM, Souder TM, McLendon C, Merit SL, Piper SC, Jansen KR, Golde TE (2003) Overexpression of nicastrin increases Abeta production. FASEB J 17:1138\u20131140","journal-title":"FASEB J"},{"key":"8092_CR71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X","volume":"48","author":"AM Fagan","year":"2000","unstructured":"Fagan AM, Younkin LH, Morris JC, Fryer JD, Cole TG, Younkin SG, Holtzman DM (2000) Differences in the Abeta40\/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 48:201\u2013210","journal-title":"Ann Neurol"},{"key":"8092_CR72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano P, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523\u2013527","journal-title":"Nature"},{"key":"8092_CR73","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1523\/JNEUROSCI.17-18-07053.1997","volume":"17","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, Hyman BT (1997) Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17:7053\u20137059","journal-title":"J Neurosci"},{"key":"8092_CR74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99\u2013102","journal-title":"Science"},{"key":"8092_CR75","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","volume":"56","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT (1997) APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56:965\u2013973","journal-title":"J Neuropathol Exp Neurol"},{"key":"8092_CR76","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jalz.2009.03.002","volume":"5","author":"TA Kokjohn","year":"2009","unstructured":"Kokjohn TA, Roher AE (2009) Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions. Alzheimers Dement 5:340\u2013347","journal-title":"Alzheimers Dement"},{"key":"8092_CR77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ab.2007.08.019","volume":"371","author":"X Jiang","year":"2007","unstructured":"Jiang X, Cheng H, Yang K, Gross RW, Han X (2007) Alkaline methanolysis of lipid extracts extends shotgun lipidomics analyses to the low abundance regime of cellular sphingolipids. Anal Biochem 371:135\u2013145","journal-title":"Anal Biochem"},{"key":"8092_CR78","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00005072-199511000-00010","volume":"54","author":"M Gearing","year":"1995","unstructured":"Gearing M, Schneider JA, Robbins RS, Hollister RD, Mori H, Games D, Hyman BT, Mirra SS (1995) Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease. J Neuropathol Exp Neurol 54:833\u2013841","journal-title":"J Neuropathol Exp Neurol"},{"key":"8092_CR79","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/mi.2.6.363","volume":"2","author":"KR Bales","year":"2002","unstructured":"Bales KR, Dodart JC, DeMattos RB, Holtzman DM, Paul SM (2002) Apolipoprotein E, amyloid, and Alzheimer disease. Mol Interv 2:363\u2013375","journal-title":"Mol Interv"},{"key":"8092_CR80","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","volume":"106","author":"DE Kang","year":"2000","unstructured":"Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH (2000) Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 106:1159\u20131166","journal-title":"J Clin Invest"},{"key":"8092_CR81","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF03401785","volume":"6","author":"YM Kuo","year":"2000","unstructured":"Kuo YM, Crawford F, Mullan M, Kokjohn TA, Emmerling MR, Weller RO, Roher AE (2000) Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease. Mol Med 6:430\u2013439","journal-title":"Mol Med"},{"key":"8092_CR82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jnr.10585","volume":"72","author":"M Michikawa","year":"2003","unstructured":"Michikawa M (2003) Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? J Neurosci Res 72:141\u2013146","journal-title":"J Neurosci Res"},{"key":"8092_CR83","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001854","volume":"11","author":"IJ Martins","year":"2006","unstructured":"Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN (2006) Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 11:721\u2013736","journal-title":"Mol Psychiatry"},{"key":"8092_CR84","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jalz.2009.02.006","volume":"5","author":"K Nichol","year":"2009","unstructured":"Nichol K, Deeny SP, Seif J, Camaclang K, Cotman CW (2009) Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement 5:287\u2013294","journal-title":"Alzheimers Dement"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-009-8092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-009-8092-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-009-8092-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T20:49:15Z","timestamp":1634676555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-009-8092-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,7]]},"references-count":84,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["8092"],"URL":"https:\/\/doi.org\/10.1007\/s12035-009-8092-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,7]]}}}